PD Dr. Dr. Imke Atreya

Medizinische Fakultät

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article Transcriptomes of MPO-deficient patients with generalized pustular psoriasis reveals expansion of CD4+cytotoxic T cells and an involvement of complement system and interferon pathways (2021) Hüffmeier U, Frey B, Becker I, Atreya I, Berking C, Moessner R, Wilsmann-Theis D, et al. Conference contribution Residual homing of alpha 4 beta 7-expressing beta 1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab (2021) Becker E, Dedden M, Gall C, Wiendl M, Ekici AB, Schulz-Kuhnt A, Schweda A, et al. Journal article Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021) Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME Journal article Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time (2021) Wirtz S, Schulz-Kuhnt A, Neurath M, Atreya I Journal article, Review article Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases (2021) Schulz-Kuhnt A, Neurath M, Wirtz S, Atreya I Journal article, Review article Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation (2020) Schulz-Kuhnt A, Wirtz S, Neurath M, Atreya I Journal article, Review article ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure (2020) Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Döbrönti M, Zirlik S, Fuchs F, et al. Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article